FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On May 24, 2004
Table of Contents
Docket # Title
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2003D-0538 Guidance for Industry and FDA Staff: FDA and Industry Actions on Premarket Notification Submissions 510(k): Effect on FDA Review Clock and Performance Assessment
2004P-0243 Oxycodone and Acetaminophen tablet USP, 2.5 mg/400 mg. 5 mg/400 mg,7.5 mg/ 400 mg and 10 mg/400 mg
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 6829 Sarah Beck Vol #: 235
EMC 6830 B. Dyke Vol #: 235
EMC 6831 S. F. Parnes Vol #: 235
EMC 6832 J. Pence Vol #: 235
EMC 6833 V. Siauw Vol #: 235
EMC 6834 J. Baldwin Vol #: 235
EMC 6835 J. Oneil Vol #: 235
EMC 6836 C. J. Heilman Vol #: 235
EMC 6837 S. Langnas Vol #: 235
EMC 6838 E. Viernes Vol #: 235
EMC 6839 E. T. Kimball Vol #: 235
EMC 6840 L. D. Mabbott Vol #: 235
EMC 6841 Dorothy Flowers Vol #: 235
EMC 6842 R. Graves Vol #: 235
EMC 6843 E. M. Schneider, M.D. Vol #: 235
EMC 6844 B. Clark Vol #: 235
EMC 6845 M. L. Hicks Vol #: 235
EMC 6846 R. Martine Vol #: 235
EMC 6847 C. Wilson Vol #: 235
EMC 6848 M. Azawi Vol #: 235
EMC 6849 J. Kim Vol #: 235
EMC 6850 Cj Dupont Vol #: 235
EMC 6851 D. Wwelch Vol #: 235
EMC 6852 CJ Dupont Vol #: 235
EMC 6853 Thalia Johnson Vol #: 235
EMC 6854 R. Wickberg Vol #: 235
EMC 6855 S. Steffy Vol #: 235
EMC 6856 L. Walker Vol #: 235
EMC 6857 J. Suitt Vol #: 235
EMC 6858 W. Root Vol #: 235
EMC 6859 Y. Chen Vol #: 235
EMC 6860 Y. Chen Vol #: 235
EMC 6861 D. Hind Vol #: 235
EMC 6862 D. Burroughs Vol #: 235
EMC 6863 K. Burkhardt Vol #: 235
EMC 6864 R. Mesek Vol #: 235
EMC 6865 R. Mesek Vol #: 235
EMC 6866 M. J. Pane Vol #: 235
EMC 6867 G. Rainley Vol #: 235
EMC 6868 D. Melander Vol #: 235
EMC 6869 J. Espe Vol #: 235
EMC 6870 E. Frampton Vol #: 235
EMC 6871 K. Meagher Vol #: 235
EMC 6872 Erlene Jackson Vol #: 235
EMC 6873 G. Pollak Vol #: 235
EMC 6874 Sara Nay Feltner Vol #: 235
EMC 6875 C. Westervelt Vol #: 235
EMC 6876 S. Pitcher Vol #: 235
EMC 6877 K. Simmons Vol #: 235
EMC 6878 D. J. Volatile Vol #: 234
EMC 6879 V. Vantuil Vol #: 235
EMC 6880 J. Ferraro Vol #: 235
EMC 6881 Kathleen Cutler Vol #: 235
EMC 6882 M. K. Marin Vol #: 235
EMC 6883 Y. Bolitho Vol #: 235
EMC 6884 E. Schmitz Vol #: 235
EMC 6885 P. Clark Vol #: 235
EMC 6886 E. Snyder Vol #: 235
EMC 6887 J. Bello Vol #: 235
EMC 6888 E. Snyder Vol #: 235
EMC 6889 L. Delap Vol #: 235
EMC 6890 J. E. Fisher Vol #: 235
EMC 6891 S. Greenwald Vol #: 235
EMC 6892 Tammy Leech Vol #: 235
EMC 6893 V. McCarter Vol #: 235
EMC 6894 M. Carlisle Vol #: 235
EMC 6895 M. Steinberg Vol #: 235
EMC 6896 M. Summer Vol #: 235
EMC 6897 J. Newman Vol #: 235
EMC 6898 A. Stueve Vol #: 235
EMC 6899 M. R. Roberts Vol #: 234
EMC 6900 D. Hadler Vol #: 235
2003D-0538 Guidance for Industry and FDA Staff: FDA and Industry Actions on Premarket Notification Submissions 510(k): Effect on FDA Review Clock and Performance Assessment
NAD 1 FDA Vol #: 1
2004P-0243 Oxycodone and Acetaminophen tablet USP, 2.5 mg/400 mg. 5 mg/400 mg,7.5 mg/ 400 mg and 10 mg/400 mg
ACK 1 Lachman Consultant Services, Inc. Vol #: 1
CP 1
Attachment A, B, C
Lachman Consultant Services, Inc. Vol #: 1

Page created on May 25, 2004 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management